校長/中國醫藥大學

EDUCATION AND POSITIONS HELD:

• 1973 B.S. in Chemistry, National Taiwan University, Taiwan
• 1977 M.S. in Biochemistry, National Taiwan University, Taiwan
• 1983 Ph.D. in Biochemistry, Brandeis University, Waltham, USA
• 1984-1986 Postdoctoral Fellow, Whitehead Institute/MIT, Cambridge, USA
• 1986-1991 Assistant Professor, Department of Tumor Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
• 1991-1994 Associate Professor, Department of Tumor Biology, The University of Texas M.D. Anderson Cancer Center, Houston
• 1994-1998 Professor, Department of Tumor Biology, The University of Texas M.D. Anderson Cancer Center, USA
• 1889-2000 Professor and Chief, Section of Molecular Cell Biology, Department of Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
• 2000-2019 Professor and Department Chair (Founding Chair), Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, USA
• 2008-2019 Director, Center for Biological Pathways, The University of Texas MD Anderson Cancer Center, USA
• 2010-2019 Vice President for Basic Research, The University of Texas MD Anderson Cancer Center, USA
• 2003-2019 Ruth Legett Jones Distinguished Chair, The University of Texas MD Anderson Cancer Center, USA
• 2019 President, China Medical University, Taichung, Taiwan
• 2020 University Chair Professor, China Medical University, Taiwan

HONORS:

• 1990, 1993, 1999, 2018 John P. McGovern Outstanding Teacher Award University of Texas Health Science Center-Houston, USA (the only faculty receives this award four times)
• 1993 Faculty Achievement Award in Education, The University of Texas M. D. Anderson Cancer Center, USA
• 1998, 2017 Faculty Achievement Award in Basic Research, The University of Texas M. D. Anderson Cancer Center, USA
• 2002 Academician of the Academia Sinica, Taiwan
• 2006 Member, The University of Texas Academy of Health Science Education, USA
• 2007 Distinguished Teaching Professor, The University of Texas M. D. Anderson Cancer Center, USA
• 2010-2016 Koman Scholar, Full Member, Scientific Advisory Council, Susan G Komen, USA
• 2010 Fellow, section of Biological Sciences, American Association for the Advancement of Science (AAAS)
• 2010 Honorary President (life time), Breast Cancer Society of Taiwan
• 2011 Presidential Award, Society of Chinese Bioscientists in America
• 2011 The University of Texas M. D. Anderson Cancer Center LeMaistre Outstanding Achievement Award
• 2014 Outstanding Alumni Award, National Taiwan University, Taipei, Taiwan
• 2014-2018 Overseas Member, Scientific Advisory Board*, Institute of Molecular and Cellular Biology, A*STAR, Singapore*Co-chaired by two Nobel Laureates: Drs. Randy Schekman and Thomas Sudhof.
• 2015 Simiao Sun Award for Biomedical Achievement, Dalian Medical University Cancer Center, China
• 2015-2017 Co-Chair, AACR Annual Meeting Program Committee
• 2017 Lifetime Achievement Award, Society of Chinese Bioscientists in America
• 2017 Regents’ Outstanding Teaching Award, The University of Texas System
• 2017 Inaugural awardee of Breast Cancer Basic and Translational Research Outstanding Achievement Award, International Breast Cancer Stem Cell Symposium, Zhanjiang, Guangdong
• 2018-2019 Honorary Dean, West China School of Basic Medical Sciences & Forensic Medicine of Sichuan University, Chengdu, China
• 2018-2019 President-elect, The University of Texas Academy of Health Science Education
• 2020 Honorary Principal Academic Advisor, Taiwan Breast Cancer Society, 2020.
• 2020-2021 Member, Presidential Science Prize Steering Committee 總統科學獎委員會, Taiwan
• 2020 Member, Steering Committee 16th Outstanding Medical/Pharmaceutical Technology Award, Tien Te Lee Biomedical Foundation
• 2020 Reviewer, 24th National Chair Professor in Biology, Medicine and Agriculture, Ministry of Education.
• 2020 Member, Review Committee “Yu-Shan Scholars recruitment program”, Ministry of Education教育部「玉山學者」計畫【醫學】領域審議委員
• 2021 Member, 2021 Scientific Review on National Institute of Cancer Research, NHRI

RESEARCH INTERESTS:

My research interests are focused on the following research areas: 1) Unravel non-canonical signal pathways of Epidermal Growth Factor Receptor (EGFR); 2) Identification of crosstalk signaling pathways in cancer cells to predict resistance for targeted therapy; 3) Elucidation of posttranslational modifications that play critical roles in tumor progression; 4) Discovery of signaling pathways and key regulators that are specific and critical to cancer stem cells proliferation; 5) Development of effectively immunotherapy and study of resistant mechanisms of immunotherapy. Up to date, I have published more than 566 peer-reviewed publications. My lifetime h-index is over 150 (Google Scholar). My group collaborates with multi-disciplinary investigators. The goal is to translate bench discoveries into clinical settings.